iCardiac Closes Series A

iCardiac Technologies Inc., a Rochester, N.Y.-based commercializer of cardiac safety technologies developed at the University of Rochester Medical Center, has raised $2 million in additional Series A funding. The round total is now $4 million, from backers Advantage Capital Partners and Stonehenge Capital. www.icardiac.com